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To gain a further understanding of the regulation of
Normal fibroblasts modulate their biosynthetic activity to
human type I collagen gene expression under physi- maintain a precise balance between the synthesis and degraologic and pathologic conditions, we characterized 5.3 dation of their products during
dynamic events of tissue remodkilobase pairs (kb) of the human d(1)procollagen gene eling such as development, differentiation, and repair. It has
promoter. A series of deletion constructs containing por- been suggested that abnormalities in these regulatory mechations of the d(1)procollagen 5’-flanking region (with
nisms maybe responsiblefor the excessive extracellular matrix
end points from -5.3 kb to -84 base pairs (bp))ligated to accumulation in a variety of fibrotic diseases such as systemic
the chloramphenicol acetyltransferase (CAT) reporter sclerosis and idiopathic pulmonary fibrosis.
gene were transiently transfected into NIW3T3cells.
The collagens comprise a large family of widely distributed
Maximal CAT activity wasobservedwith
constructs proteins that play a crucial role in the maintenance of the
having 5’ end points from -804 to -174 bp. A further 5’
structural properties of the extracellular matrix. Despite the
deletion to -84 bp caused a marked reduction in CAT
activity.Cells transfected withplasmids
containing important structural and functional roles that the collagens
longer S’-flanking fragments of the al(1) procollagen play in normal tissues, the mechanisms that regulate their
CAT activity com- production are not completely understood. Variations in net
gene (-2.3 or -5.3 kb) showed reduced
pared with the -804 bp construct. The activity of the collagen production occurring during growth and differentiaal(1)procollagen promoter was much lower
in cells that tion (1-31, viral (4-6) andchemical (7-9) transformation, cytokine and growth factor modulation (10-14), and spontaneous
do not normally express type I collagen (HeLa cells)
compared with collagen-producing NW3T3 cells. The (15-17) and experimentallyinduced (18, 19) fibrotic processes
collagen
CAT activity of deletion constructs containing longer 5‘ have been ascribed to fluctuations in the steady-state
regions than -84 bp wasincreased by =2-fold in NIW3T3 mRNA levels. The regulatory mechanisms responsible for the
cells treated with transforming growth factor p l maintenance of normal procollagen mRNA levels have not been
(TGFf.31).Electrophoreticmobility shift assays indicated completely elucidated. Most of the availableevidence suggests
that protein-DNA complex formation witha probe cor- that the principal mechanisms operateat the level of transcripresponding to the -170 to -80 bp fragment of the al(1) tion, although translational
control and changes mRNAprocin
procollagen
promoter
was
markedly
enhanced
in essing and stability may also
play a role (reviewed in Refs. 20
nuclear extracts prepared from TGFpl-treated fibro- and 21). The broad spectrum of regulatory signals that can inblasts as compared withuntreated fibroblasts. TheDNA fluence collagen gene transcription suggests that the collagen
binding activity stimulated by TGFpl was specific an
for gene promoters are responsive to various trans-acting pathSpl-like sequence at positions -164 to -142 bp in the pro- ways. Several putative regulatory elements that may determine
moter. These results demonstrate that 1)there areboth the transcriptional efficiency of procollagen genes have been
positive and negative cis-actingregulatory elements in
identified in their corresponding promoters. These include the
the human al(1)procollagen promoter, 2) these regulaconsensus
TATA and CCAAT motifs as well as additional regutory regions function differently in collagen-producing
for the
and -nonproducing cells, 3) the cul(1)procollagen pro- latory elements(22-251, which are the potential targets
action
of
promoter-specific
transcription
factors
(26-31).
Furmoter contains TGFpl-responsive sequences located beactivity of some procollagen gene
tween -174 and -84 bp fromthe transcription start site, thermore, the transcriptional
and 4) TGFpl caused marked stimulation of the DNA promoters appears to be modulated by enhancer and silencer
binding activityof a nuclear factor interacting with an elements located 3‘ from the transcriptionstart site (32, 33).
Detailed characterization of the cis-acting elements involved
Spl-like binding site located within a region encompassin modulation of collagen gene expression is crucial for undering -164 to -142 bp of the al(1)procollagen promoter.
standing the physiologic and pathologic regulation of tissue
collagen deposition. The purpose of the work reported here was
to analyze the human
crl(1)procollagen gene promoter in order
to identify regulatory regions of the genethat may play a role
in the modulation of its expression under normal and pathologic conditions.

* This work was supported by Grants AM 19106 and AR 42309 from
the National Institutes of Health. The costs of publication of this article
were defrayedin part by the payment of page charges. This article
must
thereforebeherebymarked“aduertisement”inaccordancewith
18
U.S.C. Section 1734 solely to indicate this fact.
MATERIALS AND METHODS
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBankmIEMBLData Bank with accession number(s)U06669.
Construction ofPlasmids“Severa1 preliminary
steps were necessary
(1 To whom all correspondence shouldbe addressed: Thomas Jefferson to prepare fragmentswith the appropriate restrictionsites for ligations.
University, Rm. 509, Bluemle Life Sciences Bldg., 233 South 10th St., The Hind111site in pSV0 CAT’ was changedto a KpnI site, and a 1.6kb
Philadelphia, PA 19107-6700. Tel.: 215-955-5042;Fax:215-923-4649.
** Present address: Biomedical Sciences Div., Lawrence Livermore
The abbreviations used are: CAT, chloramphenicol acetyltransNational Laboratory, Livermore,CA 94550.
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KpnI-EamHI fragment was isolated. A aUI)
7 kb procollagen gene KpnI results. Alkaline phosphatase activity was assayed on 5 pl of the extracts as described by Yoon et al. (37). CAT activity in each sample was
fragment extending from -5.3 to +1.7 kb was isolated from a human
normalized to alkaline phosphatase activity to correct for differences in
cosmid clone2 and subcloned intopUC19, and the KpnI site at-5.3 kb
was changed to a NotI site to give pJH49. A HindIII-ThaI fragment, transfection efficiency.
Electrophoretic Mobility Shift Assays-Nuclear extracts were preextending from -804 to +42 bp, was subcloned into the HindIII and
pared from confluent cultures of normal human skin fibroblasts that
SnaI sites of pUC19, excised as a HindIII-KpnI fragment, and subor without TGFpl (1 or 10 ng/ml) in the
cloned into the HindIII and KpnI sites
of Bluescript KS+ t o give had been incubated with
presence of 5% fetal calf serum for 48 h according t o the method of
p804BS. The 4.5 kb NotI-Hind111 fragment from pJH49 (containing
Dignam et al. (40). Protein concentrations were determined by a dye
al(1) procollagen gene sequences from -5.3 kb to -804 bp) was then
binding assay (Bio-Rad), and the nuclear extracts were stored in 50-pl
subcloned into the NotI and HindIII sites
of p804BS to give p5.3kBS.
For the -5.3 and -804 bp constructs, the NotI-KpnI fragments from aliquots a t -70 "C until use. In order to ensure that fibroblast protein
p5.3kBS and p804BS were ligated with the 1.6 kb KpnI-EarnHI CAT biosynthesis was stimulated by TGFPI, cultures were labeled with
coding fragment into the NotI and BamHI sites of Bluescript KS+ to [14Clproline (1.5 pCi/ml) for 24hpriortoharvesting.
Only nuclear
give p5.3kal CAT and p804al CAT, respectively. For the 2.3 kb con- extracts prepared from cultures exhibiting a greater than
2-fold increase in ['4Clproline-labeled protein production over untreated culstruct, a 1.5 kb BarnHI-Hind111 fragment containing sequences from
tures were used. In a typical experiment,
a confluent 175-cm flask (lo7
-2.3 kb to -804 bp was converted to a NotI-Hind111 fragment and
cells) yielded -100 pg of crude nuclear protein.
inserted into the Not1 and HindIII sites
of p804al CAT to give p2.3kal
Probes for electrophoretic mobility shiR assays were prepared by
CAT. A series of deletions (from the HindIII siteat -804 bp in p804al
enzymatic digestion of the p804alCAT plasmid with NotI and KpnI.
CAT toward the start of transcription site) was made following the
exonuclease 111digestion procedureof Henikoff (34). Exact deletion end The resulting 431 bp fragment was gel-purified and further digested
with NaeI and Hinfl. The resulting 219 bp
NotI-Hinff (200-3) and 90 bp
points were determined
by sequencing, and clones ending at -675, -463,
-369, -174, and -84 bp were selectedfor analysis. A promoterlessCAT Hinff-NueI (200-2) fragments were purified and 5' end-labeled with
[a-32PldCTP using
the Klenow fragment of DNApolymerase I according
plasmid, pOCAT, was preparedby removing the 846 bp HindIII-KpnI
a1
to conventional procedures (41). Additional
oligonucleotide probes were
procollagen promoter fragment from p804alCAT and religating.
The sequence from -2.3 kb to -804 bp of the al(1)procollagen gene prepared by automated DNA synthesis (Applied Biosystems), and oliwas obtained from deletions made from the NotI site in p2.3kal CAT gonucleotide S p l was obtained from Stratagene. Each oligonucleotide
toward the initiationof transcription site (alsofollowing the exonucle- wasannealed
to its complementary strandand end-labeledwith
ase I11 digestion procedure). DNA sequencing of both strands was per- [y3'P1ATP using T4 polynucleotide kinase(BoehringerMannheim).
Competition studies were performed with molar excesses
of unlabeled
formed using the dideoxy chain termination procedure (35) with T7
polymerase (Sequenase,U. S. Biochemical Corp.) following the instruc- DNA fragments or double-stranded oligonucleotides. Electrophoretic
mobility assays were performed using low ionic strength buffers as
tions provided by the supplier.
described (42). Binding reactions contained5-10 pg of the nuclear exCell ~ansfections-NIW3T3 cells (obtained from the ATCC) from
subconfluent cultures were plated a t a density of 3 x lo5 celld60-mm tracts, 1-2 pg of double-stranded poly[d(I-C)I (Pharmacia LKB Biotechdish and cultured in Dulbecco's modified Eagle's medium containing
nology Inc.), and radiolabeled probes containing50,000 cpm for a total
10%calf serum. Transfections were performed
24 h later employing the
of approximately 0.5 ng. The reaction mixtures were incubated for 30
calcium phosphate co-precipitation method,
as described (36). The NIWmin on ice in a buffer containing 60 m KCl, 10 m HEPES pH 7.9, 1
3T3 cells were transfected with pg
4 of al(1)procollagen promoter-CAT l l l ~dithiothreitol, 1 m EDTA, and 5%glycerol in a total volume of 10
plasmid DNA and 0.2 pg of the pSV2AP plasmid DNA containing the p1. Protein-DNA complexes were resolved from the free probes in nonSV40 early promoter and enhancer fused to a rat alkaline phosphatase
denaturing 5% polyacrylamide gels. Electrophoresis was performed in
cDNA (kindly provided by Dr. Kyong Yoon) (37) as an internal standard. Tridglycine buffer (50 m Tris-HC1, 260 m glycine) at 120 V for 120
m e r 4 h, the cultures were subjected to15%
a glycerol shock for 3 min
min. The gels were dried under vacuum and
exposed to x-ray film with
at room temperature and then grown in fresh mediumfor 48 h before
intensifying screens at -70 "C for 1648 h.
harvesting. HeLa cells (obtained
from the ATCC) were plated in 60-mm
plastic culture dishes (3 x lo5 cellddish), and 16 h later they were
RESULTS
transfected with the plasmids with the same procedure as thatforused
Nucleotide Sequence of -2.3 k b to -804 bp Region of al(Z)
NIW3T3 cells, except that HeLa cells were cultured in minimum Eagle's medium containing 10% fetal calf serum instead of calf serum Procollagen Gene-The nucleotide sequences of the human
al(I) procollagen promoter and 5"flanking region to -804 bp
following the glycerol shock.
Effects of TGFpI-To investigate the effectsof TGFpl on the expres- have beenpreviouslyreported (23). Our results extend the
sion of the variousal(1)procollagen promoter constructs, NIW3T3
cells upstream sequence of the gene to the BarnHI site at -2.3 kb
were transfected with the deletion construct plasmids andpSV2AP
the
(Fig. 1). The only species for which the al(1) procollagen secontrol plasmid as described above. Six hours aRer the transfections,
quence in this area has been reported to date is rat (43). A
the culture media were removed, and a fresh medium containing
10%of
comparison of the nucleotide sequences of human and rat al(1)
the serum substitute Serum Plus (HazeltonBiologics) and 12.5 ng/ml
human recombinant TGFpl (NIH Bureau
of Standards, or R & D Sys- procollagen gene 5"flanking regions indicates a relatively low
tems) was added to duplicate cultures. Control cells incubated in par- overall nucleotide identity (62%). However, there are several
allel received culture medium without TGFp1. The control and TGFp1regions within the human and rat sequences (underlined in
treated cells were incubated
for a n additional 48 h and then harvested Fig. 1) that are greater than 90% identical. A search of all
for assays of CAT and alkaline phosphatase activities as described
mammalian DNA sequences in GenBank (release 80.0) rebelow.
Assays of CAT and Alkaline Phosphatase Actiuities-Cell extracts vealed no additional sequences of identity or high homology to
were prepared by mechanically detaching the cells in 1.5 ml of phos- either strand of the new upstream sequence reported here.
Deletion Analysis of 5.3 k b Upstream Sequence of the al(I)
phate-buffered saline and by centrifugation a t 5000 x g for 3 min. The
cell pellets were resuspendedin 100 plof 0.25 M Tris-HC1, pH 7.8,0.1% Procollagen Gene-To analyze sequences that may be imporTriton X-100 and sonicatedfor 15 s. CAT activity was measured
on 20-111 tant for regulation of collagen gene expression, a series of CAT
aliquots of supernatants following centrifugation of the extracts for 5
constructs with 5' end points from -5.3 kb to -84 bp were
min in a Microfuge. The supernatantswere heated for 10 min a t 60 "C
prior to the assayof CAT activity by a liquid scintillation assay using1 prepared (Fig. 2) and examined in transient transfection assays
pCi of [3Hlacetyl-CoA/sample a s described (38). In some experiments, of functional activity. To eliminate the al(1) procollagen gene
CAT activity in thecell extracts was determined employing[14C]chlor- ATG initiation codon at +120 bp and the two additional upamphenicol according to the method described by Gorman et al. (39).
stream ATG codons at +lo3and +61 bp, the 3' end point of all
The conversion of chloramphenicol to acetylated forms was quantified fragments was +42 bp. Therefore, translation should initiate
by scraping the corresponding areas from the thin layer chromatograonly at the ATG codonof the CAT gene. The plasmids were
phy plates and measuring radioactivity
by liquid scintillation spectroscopy. The two methods of assaying CAT activity yielded comparable transfected into NIW3T3 cells, and cell extracts were analyzed
ferase; kb, kilobase pairb); bp, base paids).
J. Hyland, unpublished observations.

for CAT activity. To control for differences in transfection efficiency between samples, all results were normalized to a cotransfected reference plasmid (pSV2AF'). A summary of these
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QATCCCCAAATATCCTTCAQAACCCCAQQCCCATQATQTAQCAACCCCCAATTCACACCTTQQAQQTTTC
AACTCTTCTTTAAQATQQQCQTQQQAAAQCCTQQATQQQAAACATATQQQQAQQQQCQQQQAQCTQCAQQ

-1191
-1111
-1151

CAQQAQCCCTTCTTACTACQAAAACCCAAQAAQCAAQQAAQTQQACAQQTCACTAACCCTCATACTACCA

-ao8a

AQCCCTQCQQCACCCTQCCCTAQACCACCACTCTAAATQTCTQTTCCCTCCAAAAACAQQACCCCTQTCQ

-1011

CCTATTAQQQAQQQQQTCTCTTQQAACTQACCCACAQTAQQQQQCAQQACTTTQQTQQQTTCAAQAACTQ
CCATCTCAQCACCTCAQCCCCCTAQTCCTQCCCTQCAQTCQ~QCQQQQQ~CCTQQQ€

-1941
-1671

FIG.1. Nucleotide sequence of the
5"flanking region of the humanal(1)
procollagen gene. The sequence of the
BarnHI-Hind111 fragment encompassing
positions -2292 to -798 bp is shown. Regions with greater than 90% identity to
the corresponding rat sequences (43) are
underlined.

-804

-2.3k

-1eoa

~CATCCTQQCyprrSaCQQCCAQ€CQQCCAQCCQACQTQQCTCCCTCCCCTTCTQT~CTTTTTTTT

-1731
-1661

C C C ~ C Q T T Q C ~ C C A Q C ~ Q Q Q Q Q A Q Q Q C Q T Q Q A Q A Q Q Q Q C Q Q Q Q Q Q A Q ~

-1591

~

-1511

QCTQCACAQQAQQQAQAQAAATQAACAQQQCACTQCAAQQAQACCCCCAQQCCTTCTCTCAQCCCTACAQ

-1451

AQTTTCTCAQQACQAQQTAQATTQQQQTTQAQQCAQAQCCTTQTTQQQQQAATQQQACATQQAQQAAQAA

~

C

C

C

C

Q

C

T

T

C

~

Q

A

Q

C

A

C

C

C

Q

Q

Q

Q

T

Q

Q

-1381

AQQACQTQQAQTTCTAQAQCCATCTTCCTTAQATATAQCCTQCTQTCCTTCQQQTCCCCAQACCCTTTCA

-3311

QAQTQTACAQATQATTCTCTCTQQTTCCTAAQQCATAQAQCAATQACCQQQATTTTCAAQAAAQAQATQA

-1141

QQCAQTQQQAAQTAQCCCCTAAAACAAAQTCAATCATCCTCTQCAQCCCATCCCACACCCCCAAAQQAAA

-1171

QTTTCACCCAQACACCCAAAATATCCCATACATCCCCAACACTQAQTCCAQQTACAACTQQAQAAQQQQC

-1101

TTTATQCAQCTCCCAQAAAQACACCCCTTTAQCTAAQTQCCCTCCCTCCACCCAQQTTCTCTCTQQTTTQ

-1031

ACTQTQCTQQQAAQQAQQQTCTCTAAQCAQCCCCTQQCCACAQCCATQQCAAACAAAACTCTTCTCTAAQ

-961

TCACCAATQATCACAQQCCTCCCACTAAAAATACTTCCCAACTCTQQQQTQQAAQAQTTTQQQQQATQAA

-891

TTTTTAQQQQATTQCAAQCCCCAATCCCCACCTCTQTQTCCCTAQAATCCCCCACCCCTACCTTQQCTQC

-811

TCCATCACCCAACCACCAAAQCTT

-5k

+1+42

a 1 ( 1)

II

procollagen

-5k I
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I
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0.50 f 0.08
1 .oo

I
-675 I
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FIG.2. Summary of CAT activity drivenby various lengthsof the 5'-flanking sequenceof the human al(1) procollagen gene. A
schematic linear map of p5.3Kal CAT and 5' end points of the deletion constructs are shown on the left. NIW3T3 cells were transiently
co-transfected with the al(1) procollagen-CAT constlvcts containing various lengths of promoter sequences and the alkaline phosphatase-CAT
construct; CAT and alkaline phosphatase activities were determined as described under "Materials and Methods." The
hatched bars on the right
represent CAT activity driven by each construct correctedfor alkaline phosphatase activity in the same extracts relative to the CAT activity of the
-804 bp construct. Plasmids were assayed in at least two separate transfection experiments with duplicate or triplicate determinations in each,
except for the -675 bp construct, which was used in duplicate in a single experiment. Values shown represent the average f S.E.

experiments is shown in Fig. 2. The results indicate that CAT
expression was maximal and constant in cells transfected with
promoter constructs having 5' end points from -804t o -174 bp.
A further 3'deletion to -84 bp caused a significant reduction in
CAT activity, although even this short promoter was able to
drive 10-fold higher CAT activity than the promoterless CAT
plasmid pOCAT. Plasmids containing longer 5' fragments (extending to -2.3 or -5.3 kb) showed lowerCAT activity than the
-804 bp construct (50 and 20%, respectively).
Comparison of Activity of d(I)Procollagen Promoter in Collagen-producing and -nonproducing Cells-In order to assess
the activity of cul(1) procollagen promoter sequences in a cell
line that does not normally exhibit high levels of type I collagen
gene production, constructs with end points at -5.3 kb, -2.3 kb,
and -804 bp weretransfected into HeLa cells.As shown in Fig.
3, the CAT activity driven by these three constructs was markedly lower in HeLa cells than in NIW3T3 cells. In NIW3T3
cells, CAT activity driven by the -804 bp construct was about
26-fold higher than theCAT activity observed with the promot-

erless construct pOCAT, whereas in HeLacells the relative
activity of the -804 bp construct was 10-fold lower.In contrast
to NIW3T3 cells, transfection of constructs with longer 5' sequences into HeLa cells resulted in about 2-fold greater CAT
activity than that obtained with the -804 bp plasmid. These
results suggest that the positive and negative transcriptional
regulatory regions of the cul(1) procollagen promoter function
differently in collagen-producing and -nonproducing cells.
Localization of d(I) Procollagen Promoter Regions Responsive to TGFPl-In order to localize regions within the al(1)
procollagen promoter that are responsive to stimulation by
TGFPl in the NIW3T3 cells, the effects of TGFPl on the CAT
activity in cells transfected with promoter deletion constructs
kb, and -804bpwere
with 5' end points at -5.3kb,-2.3
examined. Incubation with TGFpl for 48 h resulted in an approximately 2-fold stimulation ofCAT activity in cells transfected with each of the threeconstructs (Fig. 4), suggesting that
TGFpl-responsive elements were located within the proximal
region of the promoter 3' to the -804 bp end point. To further
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Plasmid deletion
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endpoint , -369-174
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-84 bp

,
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-2.3
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TGFn

DELETION ENDPOINT

FIG.3. Activity of the human al(1)procollagen gene promoter
in collagen-producing ( N W 3 T 3 ) and -nonproducing (HeLa)
cells. Cultured NIW3T3 and HeLa cells were transiently transfected
with various deletion constructs (described in the legend to Fig. 2)
under identical conditions. CAT activity in the cell extracts was determined following a 48-h incubation, as described under "Materials and
Methods." CAT activity driven by the individual constructs corrected for
transfection efficiency, as determined by alkaline phosphatase activity
in the same samples, is shown relative to the CAT activity of the promoterless plasmid pOCAT. The values shown represent the average *
S.E. of three separate transfections with each plasmid, each assayed in
duplicate.

r-+

-5.0

-2.3

rl
I I
4.8

-

Acetylation (%) 3.6

T

-463 -675

0

DELETION ENDPOINT
FIG.4. Effects of TCFfll on CAT activity driven by various
lengths of the S'danking sequence of the human al(1)procollagen gene. NIW3T3 cells were transiently transfected with the progressive deletion constructs derived from the p5.3KBS plasmid, as described under "Materials and Methods," and incubated in Dulbecco's
modified Eagle's medium containing 10% Serum Plus with or without
TGFpl(12.5 ng/ml) for 48 h. CAT activity of the cell extracts, corrected
for alkaline phosphatase activity, is shown relative to the -804bp
construct.

identify TGFpl-responsive sequences within the proximal region of the al(1) procollagen promoter, NIW3T3 cells were
transfected with constructs with 5' end points a t -675, -463,
-369, -174, and -84 bp or with the promoterless construct
pOCAT and incubated with TGFp1. The results indicate that
TGFpl caused a greater than 2-fold increase in CAT activity
driven by the constructs with 5"flanking regions longer than
-84 bp. In contrast, TGFpl did not stimulate theCAT activity
driven by the -84 bp promoter. A representative transfection
experiment is shown in Fig. 5. These results indicated that
TGFpl-responsive sequences are located between -174 and
-84 bp of the al(1)procollagen promoter.
Nuclear Protein Binding to d ( Z ) Procollagen Promoter in
Control and TGFpl-treated Fibroblasts-In order to elucidate

+
163

-

3.6

+

-

1.7

133

T

T

-369

-174

+

21

1)eletion endpoint (bp)
FTG. 5. Regulation of the al(1)procollagen promoter activity
by TFGfl1. A, representative CAT assay demonstrating the effect of
TGFpl on three deletion constructs of plasmid P804al CAT. NIW3T3
cells were transfected with the -369, -174, and -84 bp end point constructs. Following a 48-h incubation with or without TGFp1, CAT activity in the cell extracta was determined as described under "Materials
and Methods." Values are expressed as percentage of [14Clchloramphenicol that was acetylated. B, histogram showing results of transient
transfections of deletion constructs from four separate experiments.
CAT activity in TGFpl-treated cells (mean countdmin 2 S.E.from
duplicate determinations) is expressed relative to the CAT activity in
untreated cells (100%).

changes in trans-acting protein-DNA interactions involving the
al(1)procollagen promoter that were associated with TGFp1induced stimulation of collagen production, electrophoretic mobility shift assays were performed. For this purpose, nuclear
extracts were prepared from untreated and TGFpl-treatedfibroblasts. Two fragments (200-2 and 200-3) of the al(1)procollagen promoter region spanning the sequences from -389 to
-80 bp relative to the transcription start site were used as
probes (Fig. &I). Incubation of the 200-2 probe (-170 to -80 bp)
with nuclear extracts from untreated or TGFpl-treated cells
resulted in theformation of two complexes with retarded electrophoretic mobility (labeled R1 and R2), indicating the presence of nuclear DNA binding factorb) recognizing sequences
within the probe (Fig. 7). The intensity of the R1 and R2 complexes determined by laser densitometry of the autoradiograms
was increased 18- and 8-fold, respectively, when nuclear extracts prepared from fibroblasts that had been treated with
TGFpl(10 ng/ml) were used (Fig. 7). Competition experiments
indicated that a 4-fold molar excess of unlabeled 200-2 probe
completely prevented the formation of the R1 complex and re-
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A
Not1

200-3

200-2

Hlnfl

Nael

- F

B
sPl.1 5'- CTCCCTCCTCCTCCCCCTCTCC
SP1.2 5" GGGCACGGGCGGCCGGC
AP-1.1
5'-CCCACCTGAGGGAAGG
NF-1.1 5'- CTAACCGACCCCGGGCCC
GC
5' -ATTCGATCGGGGCGGGGCGAGC

-1 641-142

-931-77
-1751-160 (reverse)
-102/-85 (reverse)

FIG.6. Locations and sequences
of the probes used in electrophoretic mobility shift assays.
A, 200-2 and 200-3 fragments and the
Spl-, AP-1-, and NF-1-like elements in theproximal region of the al(1)
procollagen promoter are shown. The arrow indicates the transcription
start site. B, nucleotide sequences of the sense (Spl.1 and Sp1.2) or
antisense ("1.1
and NF-1.1)strands of the binding site oligonucleotides used. The core motifs are shown in boldface. The GC-box oligonucleotide contains the S p l consensus binding sequence.
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FIG.7. .Electrophoretic mobility shift assay with competing
unlabeled DNA.A90 bp double-stranded fragment of the humancrl(1)
procollagen gene promoter encompassing the sequence from positions
-170 to -80 bp (200-2) was end-labeled and used as a probe in electrophoretic mobility shift assays. Labeled probes were incubated with 1pg
of poly[d(I-C)l and 5 pg of nuclear extracts prepared from normal human dermal fibroblasts that had been treated with TGFpl (1 or 10
ng/ml) or left untreated for 48 h. Reactions were carried out in the
absence or presence of 4- and 25-fold molar excesses of unlabeled 200-2
DNA probe, and theformation of DNA-protein complexes was analyzed
by electrophoresis in 5% polyacrylamide gels under nondenaturing conditions. The two slowly migrating DNA-protein complexes are labeled
R l and R2. Lane 1,control containing the labeled probe but no protein.

duced by about 60% the formation of the R2 complex with the
labeled 200-2 probe. A 25-fold molar excess of unlabeled 200-2
probe did not completely prevent the formation of the R2 complex (Fig. 7). These results suggest substantial differences in
the DNA binding affinities of these nuclear proteins. Several
DNA-protein complexes were detected when nuclear extracts
were incubated with probe 200-3,spanning the sequences from
-389 to -170 bp (results not shown). However, in contrastto the
results obtained with the 200-2 probe, no qualitative or quantitative differences in DNA-proteincomplex formation were
noted when the binding of nuclear proteins prepared from untreated or TGFpl-treated cells to the 200-3 probe was examined. The increase in nuclear binding activity specific for the
200-2 probe in extracts preparedfrom TGFpl-treated cells suggested the enhancement of either the synthesis or the DNA
binding activity of trans-acting factors recognizing an element(s) located within the -170 to -80 bp region of the al(1)
procollagen promoter.

Binding of Nuclear Proteins from Control or TGFpl-treated
Fibroblasts to Oligonucleotides withSpl-like Binding Sequences-A detailed analysis of the nucleotide sequence of the
-170 to -80 bp region of the humanal(1)procollagen promoter
revealed two regions ofhomology with consensus sequences
recognized by the transcription factor Spl, here designated
Spl.1 and Sp1.2 (44, 45). To determine whether nuclear proteins from human fibroblasts may interact with theseSp-1-like
elements in theal(1)procollagen promoter, electrophoretic mobility shiftassays were performed withsynthetic doublestranded oligonucleotidescorresponding to the Spl.1 and
Sp1.2
sequences as well as with oligonucleotides corresponding to
promoter sequences that display homology with the AP-1and
NF"1consensus binding elements. The location and nucleotide
sequences of these potential regulatory elements in the al(1)
procollagen promoter are shown in Fig. 6. Upon incubation of
the Spl.1probe with nuclear extracts prepared from untreated
fibroblasts, two distinct DNA-protein complexes,designated R1
(upper, a duplex) and R2 (lower), were detected (Fig. 8A). In
nuclear extracts prepared from fibroblasts treated with TGFp1,
a reproducible 4-fold increase in theintensity of the R1 complex
and a less consistent 30% increase in the intensity of the R2
complex were noted compared with the intensity of the corresponding complexes formed with nuclear extracts from untreated fibroblasts. Essentially no complex formation was detected when Sp1.2 was used as the probe (Fig. 8A). To
determine whether the formation of the R1 and R2 complexes
resulted fromspecific protein interactionswith theSpl.1
probe, competition experiments with increasing amounts
of unlabeled oligonucleotides containing theSpl.1 or Sp1.2 sequences or the Splconsensus binding site were performed. As
shown in Fig. 8B, the formation of the R2 complex was completely prevented by the addition of excess unlabeled Spl.1
oligonucleotide, whereas excess Sp1.2 or consensus S p l oligonucleotides failed to compete for binding. In contrast, the formation of the R1 duplex was markedly reduced by each of the
three competitor oligonucleotides. Incubation of the nuclear
extracts with the AP-1.1 or NF-1.1 oligonucleotide probes resulted in the formation of single DNA-protein complexes (Fig.
8C). However, in contrast to results obtained with the Spl.1
probe, there were no differences in the intensities of proteinDNA complexes when nuclear extracts prepared from untreated or from TGFpl-treated fibroblasts were used. These
results indicate that a nuclear trans-actingprotein binds to the
of the
Spl.1 element at -164 to -142 bp on the antisense strand
al(1)procollagen promoter and that thisDNA binding activity
is increased by treatment of human fibroblasts with TGFp1. An
additional DNA-protein complex (R2) is formed with this Sp-llike element, but this binding activity is less consistently increased by TGFP1.
DISCUSSION

The mechanisms involved in the regulation of collagen production under normal or pathologic conditions are not completely understood (reviewed in Refs. 20 and 21). Although the
synthesis of most proteins in eukaryotic cells appears to be
regulated at a transcriptional level, post-transcriptional
events, suchas theregulation of the stability of newly synthesized mRNA, may play an important role under certainconditions (46,47). Studiesof the transcriptional regulation of various collagen genes in human and rodent cells in vitro have
demonstrated the presence of regulatory elements located immediately 5' upstream of the transcription initiation site (2226). In addition, an enhancer element located within the first
intron hasbeen identified in thetype I collagen genes (32-34).
Sequences located far upstream of the initiation of the transcription site may also beinvolved in theregulation of expres-
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sion of the collagen genes (48, 49). Rippc et al. (49) analyzed
murine al(1)procollagen gene sequences encompassing -3700
to +1400 bp and found that a short segment of the promoter
(220 bp upstream from the start of the transcription site)was
sufficient for expression of the gene, whereasfurther upstream
flanking sequences had a negative effect on transcription.
In order to
identify upstream elements thatmay be involved
in the regulation of transcription of the human al(1)procollagen gene, we determined the nucleotide sequence of the promoter region encompassing from -804 to -2292 bp. Comparison
of the newly obtained sequence with
that of the promoter region
in the ratcrl(1) procollagen gene (43) indicated less than 65%
overallnucleotide
identity. However, several regions with
highly conserved sequences in the two species were found between -1900 and -1540 bp (underlined in Fig. l).The high
degree of nucleotide sequence conservation between the two
species in this region suggests that thesesequences may have
important regulatory functions. In the rat gene, this region
contains two repeats that are variations of the palindromic
sequence CCCTCCC. Analysis of the newly obtained
sequences
of the human gene reported here demonstrated two identical
palindromes localized at -1687 and -1063 bp. Other putative
regulatory sequences were also
identified in thenewly obtained
sequence. These included two S p l binding sites (GGGCGG) a t
positions -2168 and -1614 bp and one NF-1 (half-site) binding
sequence (GCCAA) at position -830 bp (reverse strand).
To perform
functional
a
analysis ofupstream
the
sequences,
several chimeric constructs containing DNA fragments
spanning up to-5.3 kb of the al(1)procollagen promoter ligated to
the CAT gene were prepared, and their expression was examined following transient transfection into NIW3T3 cells. Maximal transcriptional activitywas noted when promoter sequences with5' end points from -176 to -804 bp were included.
Constructs containing
upstream
further
sequences showed progressively decreasing activity (Fig.2). These results are similar
to thosereported by Rippe et al. (49) for the murine al(1)
procollagen gene.
In order to examine if there were differences in the regulation of al(1)procollagen gene transcription incells that constitutively produce high levels of collagen and cells that normally
do not disdav
of interstitial collagen genes, we com. "exmession
.
pared theexpression of the promoter-CAT constructs following
their transfection into NIW3T3 cells or into HeLa cells.
Marked differences in the expression of the promoter were
observed between these two types of cells. Transfection of noncollagen-producing HeLa cells resulted in relatively low levels
ofCAT activity, which, in marked contrast to NIW3T3 cells,
was increased when promoter constructs containing -2.3 and
-5.3 kb upstream sequences were examined (Fig. 3). The dif"
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FIG.8. Electrophoretic mobility shift assay with Spl.1 and
Sp1.2 probes and competitors. Panel A, the 23 bp Spl.1 and the

17 bpSp1.2 double-stranded oligonucleotides encompassing the human
al(1)procollagen promoter sequences-164 to -142 bp or -93 to -77 bp,
respectively, were end-labeled and used a s probes in electrophoretic
mobility shift assays. Nuclear extracts were prepared
from normal human skin fibroblasts that had been treated with TGFpl (10
ng/ml) or
left untreated for 48 h. Labeled probes were incubated with nuclear
extracts under identical conditions,
a s described in the
legend to Fig. 7.
The positionsof the shifted complexes ( R l and R2)are indicated, along
with the position of the unbound DNA. Lane 1, control containing labeled Spl.1 probe but no protein. c, nuclear extract prepared from
untreated fibroblasts;T,nuclear extract preparedfrom TGFpl-treated
fibroblasts. Panel B, same aspanel A, except that only the Spl.1oligonucleotide probe and increasing concentrations
(2.5-, loo-, and250-fold
molar excesses) of unlabeled double-stranded competitor oligonucleotides were used. Nuclear extracts were prepared from TGFpl (10 npl
mbtreated fibroblasts, except in
lane 2 ( C ,untreated fibroblasts). Panel
C, same as panel A, except the "1.1
and NF-1.1 oligonucleotides,
corresponding to the al(1) procollagen gene sequence from positions
-175 to -166 bpand-102to-85-bp,respectIvely,wereused.The
arrowhead denotes the retarded DNA-protein complex (RI).

12690

Human d ( I ) Procollagen Gene Promoter

ferences in expression of the various constructs when transfected into collagen-producing and -nonproducing cell types
suggest that the intracellular
milieu playsan importantrole in
the regulation of the rates at which the collagen genes are
transcribed. Furthermore, these results suggest that cell-specific transcriptional factors that acton the upstreamsequences
of the al(1) procollagen gene may influence the expression of
this gene.
To further investigate the functional role that the al(1)procollagen promoter may play during dynamic events requiring
remodeling of the extracellular matrix,
we examined the effects
of TGFpl on the expression of the variouspromoter constructs.
It has been suggested that this growth factor acting in autocrine and paracrine fashion plays a n important role in the
regulation of extracellular matrix metabolism during development, differentiation, and repair(reviewed in Refs. 50 and 51).
TGFp causes marked accumulation of collagen in vivo and in
vitro (52, 53). In animal models of hepatic and pulmonary fibrosis, TGFp mRNA is expressed in high levels in tissuesprior
to the development of fibrosis (54-56). Furthermore, recent
observations implicate TGFp in the pathogenesis of various
human diseases characterized by exaggerated fibrosis (57-60).
In the present study, we found that TGFpl stimulated CAT
activity drivenby al(1)procollagen promoter constructs with 5'
end points distal to -84 bp in transiently transfectedNIW3T3
cells. These results indicate that TGFpl-responsive
sequences
in the human al(1)procollagen promoter are located between
-174 and -84 bp from the transcription start site.
To determine if TGFpl induced alterations in DNA binding
activity in fibroblasts, we examined DNA-protein complex formation in nuclear extracts prepared from TGFpl-treated and
untreated cells by electrophoretic mobility shift analysis using
DNA probes spanning the proximal region of the al(1)procollagen promoter. The resultsshowed a marked increase in DNA
binding activity that was specific for the probe encompassing
nucleotides -170 to -80 bp in nuclear extracts from TGFp1treated cells. This region of the human al(1) procollagen promoter contains a binding site for S p l at -87 bp and an element
with complete identity to the 3' portion of the canonical NF-1binding motif (GCCAA), located in reverse orientation at -95
bp. These overlapping potential bindingsites havebeen shown
to be important in the basal expression of the mouse al(1)
procollagen gene (29). In addition, a sequence similar to the
AP-1-binding site (5"GAGTCC) is located in reverse orientation at -165 bp, and a sequence of perfect identity with a
binding site for an Spl-like factor from the GC2 cis-acting
element of the rat growth hormone and the F2 elementof the
human growth hormone genes (GGGAGGAG) is found at -148
bp in reverse orientation (45).When sequences in the -170 to
-80 bp region of the humanal(1)procollagen promoter homologous to these consensus binding sites were examined in electrophoretic mobility shift assays, only the Spl.1 probe (corresponding to the sequence
identical
with
GC2 and F2)
demonstrated increased DNA-protein complex formation with
nuclear extractsfrom TGFpl-treated when compared with untreated fibroblasts. The formation of the R1complex was abolished or decreased in competition assays with all three Splrelated oligonucleotides, in contrast to the R2 complex, which
was prevented only by the Spl.1 oligonucleotide competitor.
These observations suggest that at least
one component of the
R1 complex may be a memberof the Splfamily of transcription
factors. Of interest in this regard isprevious
the
demonstration
that Spl interacted with cis-acting elements within the first
intron (34)or the promoter (61) of the al(1) procollagen gene.
Spl, originally described as a factor required for SV40 transcription, binds to "GC boxes," which are found in the promoters of many mammalian genes (44). Although ubiquitouslyex-

pressed, recent evidence points to transcriptional regulation as
an important role for S p l (62). Overexpression of S p l was
shown to inhibit mouse al(1) procollagen promoter activity in
transiently transfected NIW3T3cells (29). However, when cotransfected into Drosophila melanogaster Schneider L2 cells,
which are devoid of homologs of mammalian transcription factors, S p l overexpression caused potent trans-activation of the
al(1) procollagen promoter (63).
In the rat al(1) and the mouse a2(I) procollagen genes,
TGFP-responsive elements resembling the NF-1 consensus sequence have been described (64, 65). In the rat al(1)procollagen gene,the putative"TGFp activating element" was reported
to be located 1.6 kb upstream from the transcriptionstart site
(65).The elementcontains the 3' portion of the canonical NF-1
sequence GCCAAG also found in the mouse a2(I) promoter.
However, incontrasttothe
mouse a2(1) procollagen gene,
stimulation of rat al(1)procollagen gene expression by TGFpl
does not apear to involve NF-1 binding to its cognate DNA
element (66). Analysis of the nucleotide sequence of the human
al(1) procollagen gene indicates that a NF-1-like sequence
similar to the rat TGFp activating element
is located at -1718
bp (5'-TGCCCACGGCCAGC). However, our results indicate
that deletion of a 1.5 kb fragment including this element did
not prevent stimulation of promoter activity by TGFpl (Fig. 41,
suggesting that in NIW3T3 cells this NF-1-like element is not
involved in TGFpl-induced transcriptional activation of the
al(1) procollagen gene. Thenature of trans-acting factors,
which are implicated in the modulation of the expression of
diverse TGFP-responsive genes, is not completely understood.
Recent studies suggest that,
depending on the cell type and the
gene that is regulated, a variety of distinct nuclear proteins
may be involved (67). Moreover, transcriptional regulation by
TGFp is likely to be a complex process, associated with the
combinatorial interactions of ubiquitous and inducible transacting factors. The identification of cell-specific DNA binding
factors and of the stimulatory and inhibitory cis-acting elements in the
promoter of the humanal(1)procollagen gene that
are targetsfor these factors will permit a better understanding
of the complex mechanisms that modulate the transcriptional
activity of collagen genes during physiologic processes of development and repair as well as in a variety of diseases characterized by excessive collagen production.
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